CareDx Inc (CareDx) is a diagnostics company focused on the discovery, development, and commercialization of diagnostic solutions for transplant patients. Its products include AlloSure, AlloMap, Qtype, Olerup SSP and SBT, Trusight, AlloSeq cfDNA, HeartCare, KidneyCare, Ottr Organ, Ottr Cellular, XynQAPI, TxAccess, XynCare, AlloCare, AlloCell and AlloSeq HCT. The company provides laboratory products along the pre and post-transplant testing continuum including human leukocyte antigen typing kits and testing solutions. CareDx offers novel surveillance management solutions to transform long-term patient care in transplantation. Its services also include digital transplant solutions, cell transplant therapy, pharma services, patient care management, and others. The company operates in the US, Sweden, and Australia. CareDx is headquartered in South San Francisco, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company CareDx Inc
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
CareDx Inc Company Overview
CareDx Inc Company Snapshot
CareDx Inc Pipeline Products and Ongoing Clinical Trials Overview
CareDx Inc – Pipeline Analysis Overview
CareDx Inc - Key Facts
CareDx Inc - Major Products and Services
CareDx Inc Pipeline Products by Development Stage
CareDx Inc Ongoing Clinical Trials by Trial Status
Diagnostic Test - Crohn's Disease Product Overview
Diagnostic Test - Multiple Sclerosis
Diagnostic Test - Multiple Sclerosis Product Overview
Diagnostic Test - Rheumatoid Arthritis
Diagnostic Test - Rheumatoid Arthritis Product Overview
Diagnostic Test - Sjogren's Syndrome
Diagnostic Test - Sjogren's Syndrome Product Overview
Diagnostic Test - Systemic Lupus Erythematosus
Diagnostic Test - Systemic Lupus Erythematosus Product Overview
HistoMap
HistoMap Product Overview
HistoMap Clinical Trial
HistoMap Liver
HistoMap Liver Product Overview
Post Transplant Management-Lung Transplant
Post Transplant Management-Lung Transplant Product Overview
UroMap
UroMap Product Overview
CareDx Inc - Key Competitors
CareDx Inc - Key Employees
CareDx Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
CareDx Inc, Recent Developments
May 29, 2024: Caredx Reiterates Position That It Does Not Infringe The ‘544 Patent, Injunction Motion Is Irrelevant
May 16, 2024: Landmark Study Shows CareDx’s Heartcare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies
Apr 16, 2024: CareDx Appoints John W. Hanna as its New President and Chief Executive Officer
Apr 09, 2024: CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting
Feb 27, 2024: Natera Announces Next Phase of CareDx Patent Infringement Litigation Seeking Royalty For All Ongoing And Future AlloSure Tests
Feb 21, 2024: CareDx Showcases Digital Solutions and Pipeline in Cellular Transplant and Therapy Monitoring at the 2024 Tandem Meetings
Jan 26, 2024: CareDx Issues Statement in Patent Infringement Case
Jan 11, 2024: Caredx Adds to Allosure Kidney and Heartcare Utility and Clinical Data at 2024 American Society of Transplant Surgeons Winter Symposium
Dec 19, 2023: CareDx Joins Forces with the National Foundation for Transplants to Improve Post-Transplant Medication Adherence